Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency – The next disease included in the neonatal screening program in poland

1White PC, Speiser PW. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocr Rev. 2000;21:245-291.White PC Speiser PW Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr Rev 200021245 291Search in Google Scholar

2Ginalska-Malinowska M. Wrodzony przerost nadnerczy u dzieci i młodzieży – diagnostyka i leczenie. Pediatr Dypl. 2012;16:18-25.Ginalska-Malinowska M Wrodzony przerost nadnerczy u dzieci i młodzieży – diagnostyka i leczenie Pediatr Dypl 20121618 25Search in Google Scholar

3Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HFL, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4133-4160.Speiser PW Azziz R Baskin LS Ghizzoni L Hensle TW Merke DP Meyer-Bahlburg HFL Miller WL Montori VM Oberfield SE Ritzen M White PC Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab 2010954133 416010.1210/jc.2009-2631Search in Google Scholar

4Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048-4053.Clayton PE Miller WL Oberfield SE Ritzen EM Sippell WG Speiser PW Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology J Clin Endocrinol Metab 2002874048 405310.1210/jc.2002-020611Search in Google Scholar

5Romanowska H, Krzywińska-Zdeb E, Walczak M, Giżewska M. Wrodzony przerost nadnerczy u noworodka. Pediatr Dypl. 2017;21:25-31.Romanowska H Krzywińska-Zdeb E Walczak M Giżewska M Wrodzony przerost nadnerczy u noworodka Pediatr Dypl 20172125 31Search in Google Scholar

6Ballerini MG, Chiesa A, Scaglia P, Gruñeiro-Papendieck L, Heinrich JJ, Ropelato MG. 17alpha-hydroxyprogesterone and cortisol serum in neonates and young children: influence of age, gender and methodological procedures. J Pediatr Endocrinol Metab. 2010;23:121-132.Ballerini MG Chiesa A Scaglia P Gruñeiro-Papendieck L Heinrich JJ Ropelato MG 17alpha-hydroxyprogesterone and cortisol serum in neonates and young children: influence of age, gender and methodological procedures J Pediatr Endocrinol Metab 201023121 13210.1515/JPEM.2010.23.1-2.121Search in Google Scholar

7Pang SY, Wallace MA, Hofman L, Thuline HC, Doche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866-874.Pang SY Wallace MA Hofman L Thuline HC Doche C Lyon IC Dobbins RH Kling S Fujieda K Suwa S Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency Pediatrics 198881866 87410.1016/S0022-5347(17)42164-1Search in Google Scholar

8White PC. Optimizing Newborn Screening for Congenital Adrenal Hyperplasia. J Pediatr. 2013;163:10-12.White PC Optimizing Newborn Screening for Congenital Adrenal Hyperplasia J Pediatr 201316310 1210.1016/j.jpeds.2013.02.00823522380Search in Google Scholar